Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062552/0601 | |
| Pages: | 21 |
| | Recorded: | 01/31/2023 | | |
| Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17601611
|
Filing Dt:
|
10/05/2021
|
|
Publication #:
|
|
Pub Dt:
|
05/25/2023
| | | | |
|
Title:
|
METHOD FOR ENHANCING CELLULAR IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17601611
|
Filing Dt:
|
10/05/2021
|
|
Publication #:
|
|
Pub Dt:
|
05/25/2023
| | |
PCT #:
|
US2026778
|
|
Title:
|
METHOD FOR ENHANCING CELLULAR IMMUNOTHERAPY
|
|
|
Assignor
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
|
|
Newly Merged Entity's New Name
|
|
|
|
|
| 1100 FAIRVIEW AVENUE N. |
| SEATTLE, WASHINGTON 98109 |
|
|
Correspondence name and address
|
| |
NEKTAR THERAPEUTICS
|
| |
455 MISSION BAY BOULEVARD SOUTH
|
| |
SUITE 100
|
| |
SAN FRANCISCO, CA 94158
|
Search Results as of:
05/24/2024 12:47 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
